Dysregulation of BMP4 receptor trafficking and signaling in fibrodysplasia Ossificans Progressiva

Clinical Reviews in Bone and Mineral Metabolism

Volumn 3, Issue 3-4, 2005, Pages 217-223

  Kaplan, Frederick S ^a   Fiori, Jennifer L ^a   Serrano De La Peña, Lourdes ^a   Ahn, Jaimo ^a   Billings, Paul C ^a   Shore, Eileen M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BMP receptors; BMP4; Fibrodysplasia ossificans progressiva (FOP); Heterotopic ossification

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4 RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; DISEASE COURSE; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; GENE MUTATION; HETEROTOPIC OSSIFICATION; HUMAN; JOINT MALFORMATION; MUTAGENESIS; OSSIFYING MYOSITIS; PERINATAL PERIOD; PROTEIN DEFECT; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TOE MALFORMATION;

EID: 25844482558     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:3:3-4:217     Document Type: Article

References (44)

1. Cohen RB, Hahn GV, Tabas J, et al. 1993 The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 75-A:215-219.
2. Kaplan FS, Tabas J, Gannon FH, Finkel G, Hahn GV, Zasloff MA. 1993 The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg 75-A:220-230.
3. Kaplan FS, McCluskey W, Hahn G, Tabas J, Muenke M, Zasloff MA. 1993 Genetic transmission of fibrodysplasia ossificans progressiva. J Bone Joint Surg 75-A:1214-1220.
4. Gannon FH, Valentine BA, Shore EM, Zasloff MA, Kaplan FS. 1998 Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 346:19-25.
5. Kaplan FS, Glaser DL, Hebela N, Shore EM. 2004 Heterotopic ossification. J Am Acad Orthop Surg 12:116-125.
6. Kaplan FS, Shore EM, Connor JM. 2002 Fibrodysplasia ossificans progressiva (FOP). In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd Ed. Wiley-Liss; John Wiley & Sons, New York, pp. 827-840.
7. Kaplan FS, Tabas JA, Zasloff MA. 1990 Fibrodysplasia ossificans progressiva: A clue from the fly? Calcif Tiss Int 47:117-125.
8. Shafritz AB, Shore EM, Gannon FH, et al. 1996 Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561.
9. Gannon FH, Kaplan FS, Olmsted E, Finkel G, Zasloff MA, Shore EM. 1997 Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum Pathol 28:339-343.
10. Kaplan FS, Shore EM. 1998 Encrypted morphogens of skeletogenesis: biological errors and pharmacological patients. Biochemical Pharmacology 55:373-382.
11. Olmsted EA, Kaplan FS, Shore EM. 2003 Bone morphogenetic protein 4 regulation in fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 408:331-343.
12. Ahn J, Serrano de la Peña L, Shore EM, Kaplan FS. 2003 Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg 85-A:667-674.
13. Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan, FS, Shanahan CM. 2003 Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification. J Pathol 201:141-148.
14. Glaser DL, Economides AN, Wang L, et al. 2003 In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg 85-A:2332-2342.
15. Kaplan FS. 1998 The metamorphosis. Clin Orthop Relat Res 346:2-3.
16. Xu M-Q, Feldman G, Le Merrer M, et al. 2000 Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva. Clin Genet 58:291-298.
17. Dunn NR, Winnier GE, Hargett LK, Schrick JJ, Fogo AB, Hogan BL. 1997 Haploinsufficient phenotypes in BMP4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev Biol 188:235-247.
18. Massagué J, Blain SW, Lo RS. 2000 TGF beta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
19. Shi Y, Massague J. 2003 Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
20. Canalis E, Economides AN, Gazzerro E. 2003 Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235.
21. Urist MR. 1965 Bone formation by autoinduction. Science 150:893-899.
22. Wozney JM, Rosen V, Celeste AJ, et al. 1988 Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
23. Kan L, Hu M, Gomes WA, Kessler JA. 2004 Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107-1115.
24. Attisano L, Wrana JL. 2000 Smads as transcriptional co-modulators. Curr Opin Cell Biol 12:235-243.
25. Derynck R, Zhang YE 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584.
26. Serrano de la Peña L, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM. 2005 Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res 20:1168-1176.
27. Tabas JA, Hahn GV, Cohen RB, et al. 1993 Chromosomal assignment of the human gene for bone morphogenetic protein 4. Clin Orthop Relat Res 293:310-316.
28. Shore EM, Xu M-Q, Shah PB, et al. 1998 The human bone morphogenetic protein (BMP-4) gene: molecular structure and transcriptional regulation. Calcif Tissue Int 63:221-229.
29. Xu MQ, Shore EM. 1998 Mutational screening of the bone morphogenetic protein 4 gene in a family with fibrodysplasia ossificans progressiva. Clin Orthop 346:53-58.
30. Feldman G, Li M, Martin S, et al. 2000 Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. Am J Hum Genet 66:128-135.
31. Zimmerman LB, De Jesus-Escobar JM, Harland RM 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606.
32. Brunet LJ, McMahon JA, McMahon AP, Harland RM. 1998 Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Nature 280:1455-1457.
33. Gazzerro E, Gangji V, Canalis E. 1998 Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102:2106-2114.
34. Groppe J. Greenwald J, Wiater E, et al. 2002 Structural basis of BMP signaling inhibition by the cystine knot protein Noggin. Nature 420:636-642.
35. Groppe J. Greenwald J, Wiater E, et al. 2003 Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membraned cystine knot protein. J Bone Joint Surg Am 85-A(Suppl 3):52-58.
36. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P. 2000 Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11:1023-1035.
37. Nohe A, Hassel S, Ehrlich M, et al. 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277:5330-5338.
38. Hoffmann A, Gross G. 2001 BMP signaling pathways in cartilage and bone formation. Critical Reviews in Eukaryotic Gene Expression 11:23-45.
39. Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM. 2000 The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127:621-630.
40. Panchison DM, Pickel JM, Studer L, et al. 2001 Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev 15:2094-2110.
41. Rauch C, Brunet AC, Deleule J, Farge E. 2002 C2C12 myoblast/osteoblast transdifferentiation steps enhanced by epigenetic inhibition of BMP2 endocytosis. Am J Physiol Cell Physiol 283:C235-243.
42. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. 2003 Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5:410-421.
43. Gilboa L, Wells RG, Lodish HF, Henis YI. 1998 Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane. J Cell Biol 140:767-777.
44. Dore JJ Jr, Edens M, Garamszegi N, Leof EB. 1998 Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells. J Biol Chem 273:31,770-31,777.